Large‐scale genomic sequencing reveals adaptive opportunity of targeting mutated‐PI3Kα in early and advanced HER2‐positive breast cancer

BACKGROUND: Few studies have discussed the contradictory roles of mutated‐PI3Kα in HER2‐positive (HER2+) breast cancer. Thus, we characterised the adaptive roles of PI3Kα mutations among HER2+ tumour progression. METHODS: We conducted prospective clinical sequencing of 1923 Chinese breast cancer pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lin‐Wei, Li, Xiao‐Guang, Yang, Yun‐Song, Lu, Xun‐Xi, Han, Xiang‐Chen, Lang, Guan‐Tian, Chen, Li, Shao, Zhi‐Ming, Hu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567053/
https://www.ncbi.nlm.nih.gov/pubmed/34842356
http://dx.doi.org/10.1002/ctm2.589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567053/
https://www.ncbi.nlm.nih.gov/pubmed/34842356
http://dx.doi.org/10.1002/ctm2.589

Ejemplares similares